(Q53201630)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932117%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932117%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932117%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Jean-Mathieu Beauregard

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932117%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Michael S Hofman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932117%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Grace Kong

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932117%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

20 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932117%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Nuclear Medicine and Molecular Imaging

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932117%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932117%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932117%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

50-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932117%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-011-1937-3

13 February 2020

exact match

0 references

cites work

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1937-3

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1937-3

Individualized dosimetry in patients undergoing therapy with (177)Lu-DOTA-D-Phe (1)-Tyr (3)-octreotate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1937-3

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1937-3

68Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1937-3

Molecular imaging with ⁶⁸Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1937-3

Should clearance be normalised to body surface or to lean body mass?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1937-3

Metabolic Super Scan in 18F-FDG PET/CT Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1937-3

Quantitative (177)Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1937-3

Pharmacological properties of hydrophilic and lipophilic derivatives of octreotate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1937-3

Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1937-3

Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of (86)Y-DOTATOC and (111)In-DTPA-octreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1937-3

177Lu-octreotate, alone or with radiosensitising chemotherapy, is safe in neuroendocrine tumour patients previously treated with high-activity 111In-octreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1937-3

Simplified calculation of body-surface area.

21 January 2018

1 reference

12 December 2020

Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions

1 reference

12 December 2020

Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats.

1 reference

12 December 2020

Processing of generator-produced 68Ga for medical application.

1 reference

12 December 2020

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

1 reference

12 December 2020

Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model

1 reference

12 December 2020

10.1007/S00259-011-1937-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932117%20AND%20SRC:MED&resulttype=core&format=json

release_2pown32abnfcblr63dw3cg7sfa

13 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2pown32abnfcblr63dw3cg7sfa

24 November 2022

mapped directly with Wikidata item

1 reference